Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Liver Neoplasms × atezolizumab × Clear all

Status

Sponsor Class

Study Type

Interventional 11 Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 10 Carcinoma, Hepatocellular 6 Carcinoma, Transitional Cell 4 Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Small Cell Lung Carcinoma 2 Breast Neoplasms 2 Unresectable Hepatocellular Carcinoma 1 Liver Neoplasms 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Hepatectomy 8 Blood Specimen Collection 8 Sorafenib 5 Polymerase Chain Reaction 4 regorafenib 3 Mass Spectrometry 3 Liver Transplantation 3 Immunohistochemistry 3 Chemoembolization, Therapeutic 3 Biopsy 3 Surveys and Questionnaires 2 Magnetic Resonance Imaging 2 Gene Expression Profiling 2 trastuzumab deruxtecan 1 taxane 1 spartalizumab 1 sintilimab 1 lenvatinib 1 gadolinium ethoxybenzyl DTPA 1 donafenib 1 carmofur 1 camrelizumab 1 atezolizumab 1 apatinib 1 anlotinib 1 Yttrium-90 1 Whole Genome Sequencing 1 Watchful Waiting 1 Walking Speed 1 User-Centered Design 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05713994 2025-03-25

CCGLC-001

Tongji Hospital

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡